CN1089241C - 一种能抗癌的毛蚶或魁蚶提取物 - Google Patents
一种能抗癌的毛蚶或魁蚶提取物 Download PDFInfo
- Publication number
- CN1089241C CN1089241C CN98110478A CN98110478A CN1089241C CN 1089241 C CN1089241 C CN 1089241C CN 98110478 A CN98110478 A CN 98110478A CN 98110478 A CN98110478 A CN 98110478A CN 1089241 C CN1089241 C CN 1089241C
- Authority
- CN
- China
- Prior art keywords
- arca
- extract
- subcrenata
- scapharca
- anticancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000628923 Anadara sativa Species 0.000 title claims abstract description 11
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 10
- 241000180579 Arca Species 0.000 title abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 241001339782 Scapharca broughtonii Species 0.000 claims description 9
- 230000007062 hydrolysis Effects 0.000 claims description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000000502 dialysis Methods 0.000 claims description 3
- 239000002893 slag Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 11
- 238000002360 preparation method Methods 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 3
- 102000003886 Glycoproteins Human genes 0.000 abstract description 2
- 108090000288 Glycoproteins Proteins 0.000 abstract description 2
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 239000013543 active substance Substances 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 238000003809 water extraction Methods 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000011275 oncology therapy Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000011254 conventional chemotherapy Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960002918 doxorubicin hydrochloride Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98110478A CN1089241C (zh) | 1998-09-18 | 1998-09-18 | 一种能抗癌的毛蚶或魁蚶提取物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98110478A CN1089241C (zh) | 1998-09-18 | 1998-09-18 | 一种能抗癌的毛蚶或魁蚶提取物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1248442A CN1248442A (zh) | 2000-03-29 |
CN1089241C true CN1089241C (zh) | 2002-08-21 |
Family
ID=5220526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98110478A Expired - Fee Related CN1089241C (zh) | 1998-09-18 | 1998-09-18 | 一种能抗癌的毛蚶或魁蚶提取物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1089241C (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100371347C (zh) * | 2003-09-22 | 2008-02-27 | 于荣敏 | 毛蚶中的多肽蛋白类活性物质及其制备方法和用途 |
CN101416986B (zh) * | 2008-12-10 | 2011-09-21 | 青岛海生肿瘤医院 | 蚶类提取物肠溶胶囊及其制造方法 |
CN102716153B (zh) * | 2012-06-27 | 2014-10-08 | 陈顺泰 | 一种治疗乳腺增生的复合药剂及其生产方法 |
CN103254302A (zh) * | 2013-04-01 | 2013-08-21 | 于荣敏 | 从毛蚶中分离制备一种抗肿瘤多肽化合物的方法和用途 |
CN103254303A (zh) * | 2013-04-01 | 2013-08-21 | 于荣敏 | 毛蚶中抗肿瘤活性多肽组分的制备方法和用途 |
CN107569445A (zh) * | 2017-10-20 | 2018-01-12 | 烟台宇诚企业管理咨询有限公司 | 一种基于海洋生物提取物的护发组合物及其制备方法 |
CN108497120A (zh) * | 2018-05-29 | 2018-09-07 | 广州聚禅现代农业研究院有限公司 | 一种清热利湿茶及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1132646A (zh) * | 1995-10-19 | 1996-10-09 | 黄国能 | 牡蛎螺旋藻胶囊及其制取方法 |
CN1148486A (zh) * | 1995-10-26 | 1997-04-30 | 中山大学 | 含珍珠水溶性成分的牙膏及漱口液 |
-
1998
- 1998-09-18 CN CN98110478A patent/CN1089241C/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1132646A (zh) * | 1995-10-19 | 1996-10-09 | 黄国能 | 牡蛎螺旋藻胶囊及其制取方法 |
CN1148486A (zh) * | 1995-10-26 | 1997-04-30 | 中山大学 | 含珍珠水溶性成分的牙膏及漱口液 |
Non-Patent Citations (3)
Title |
---|
中国海洋药物1996,(3) 1996.3.31 窦昌贵等毛蚶水解液对小鼠实验性肝损伤的保护作用 * |
中国海洋药物1996,(3) 1996.3.31 窦昌贵等毛蚶水解液对小鼠实验性肝损伤的保护作用;中国涨洋药物1996,(1) 1996.1.31 窦昌贵等毛蚶水解液降血糖降血脂的实验研究 * |
中国涨洋药物1996,(1) 1996.1.31 窦昌贵等毛蚶水解液降血糖降血脂的实验研究 * |
Also Published As
Publication number | Publication date |
---|---|
CN1248442A (zh) | 2000-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101451157A (zh) | 一种低分子量海参多糖的制备方法 | |
CN104151425A (zh) | 一种天然水蛭素的规模化生产方法 | |
CN108220191A (zh) | 一种微生态制剂及其制备方法与应用 | |
CN101020715B (zh) | 鹿茸神经生长因子(deer ngf)提取及其制备方法 | |
CN108785331A (zh) | 一种具有气血双补的组合物及其制备方法和应用 | |
CN1089241C (zh) | 一种能抗癌的毛蚶或魁蚶提取物 | |
CN111004829A (zh) | 一种黑木耳活性肽的制备方法 | |
CN106889295A (zh) | 一种活体海刺参活性肽的制备方法 | |
CN112791103B (zh) | 一种鹿血制品及其制备方法 | |
KR100239946B1 (ko) | 자라와 거북의 조성물 | |
CN108634296A (zh) | 一种雪峰乌鸡肽营养粉及其制备方法 | |
CN111840525A (zh) | 一种用于治疗血栓性脉管炎的组合物及其制备方法 | |
CN104544287A (zh) | 一种海产品活性营养冻干粉的制备方法 | |
CN110590908A (zh) | 一种小带鱼源抗菌肽添加剂及其制备方法 | |
CN110477402A (zh) | 鱼肽、鱼骨肽、海参肽和人参肽复合营养品及其制备方法 | |
CN105147589A (zh) | 一种去头屑组合物及其制备方法 | |
CN112516183B (zh) | 一种针对外伤具有修复作用的提取物制备方法及应用 | |
CN101647820A (zh) | 活性纯蛇粉胶囊及其制作工艺 | |
CN104738700B (zh) | 一种泥鳅护肝品及其制备方法 | |
CN106509254A (zh) | 一种青钱柳叶保健茶、片剂及其制作方法 | |
CN1586254A (zh) | 红茶香型杜仲茶及其速溶茶和水饮品制备方法 | |
CN101301075B (zh) | 一种含韭菜籽增强免疫力功能性食品及其制备方法 | |
CN101416985A (zh) | 蚶类提取物冻干粉的提取方法 | |
CN109568254A (zh) | 一种人胎盘组织液注射剂及其制备方法 | |
CN101199741B (zh) | 一种胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
C49 | Reinstatement of patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: QINGDAO GUOTAI( GROUP ) CO., LTD. Free format text: FORMER NAME: LIN HUAYING |
|
CP03 | Change of name, title or address |
Address after: 7, four stream Road, Sifang District, Qingdao, Shandong Province, zip code: 266031 Co-patentee after: Lin Hua Ying Patentee after: Qingdao Guotai (Group) Co., Ltd. Address before: Shandong province Qingdao sea Riyin Biological Products Co. Ltd., zip code: 266003 Patentee before: Lin Huaying |
|
RR01 | Reinstatement of patent right | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20020821 Termination date: 20091019 |